Text of introduction - January 2013 - International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-07-02 05:24:35 Health European Medicines Agency Summary of Product Characteristics MedDRA Adverse drug reaction Adverse effect Pseudoephedrine Pharmacovigilance Pharmacology Pharmaceutical sciences Medicine		Text of introduction - January 2013 Add to Reading List Source URL: www.imi-protect.eu Download Document from Source Website File Size: 70,33 KB Share Document on Facebook

	Reference material Standard Workflow for the Revision of Drug Product Package Inserts (Adverse Drug Reaction Reports, etc.) DocID: 1rsP1 - View Document
	Managing patients’ safety: Need for PharmacoVigilance Dr. Hanmant Barkate, MBBS, MD Associate Vice-President& Head Medical, Clinical & Regulatory affairs Intas Pharmaceuticals Ltd., Ahmedabad DocID: 1rcEG - View Document
	PHARMACOVIGILANCE GUIDE FOR ADVERSE DRUG REACTION MONITORING AND CAUSALITY ASSESSMENT, 2015 Post marketing Control Division, DocID: 1p9e5 - View Document
	REVIEW ARTICLE A New, Evidence-based Estimate of Patient Harms Associated with Hospital Care John T. James, PhD DocID: 1p3Uj - View Document
	Pharmacovigilance: Monitoring the Safety & Efficacy of Animal Medicines Summary This document DocID: 1oBM7 - View Document